A Study to Evaluate and Study Drug Levels in Blood Plasma When Giving High Doses of GSK189075 to Healthy Volunteers
NCT00501930
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
12
Enrollment
INDUSTRY
Sponsor class
Conditions
Type 2 Diabetes Mellitus
Diabetes Mellitus, Type 2
Interventions
DRUG:
GSK189075
Sponsor
GlaxoSmithKline